The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Open accessAbstract
Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of viral hepatitis, insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH), disorders that increase risk of hepatocellular carcinoma (HCC). To determine whether and how ER stress contributes to obesity-driven hepatic tumorigenesis we fed wild-type (WT) and MUP-uPA mice, in which hepatocyte ER stress is induced by plasminogen activator expression, with high-fat diet. Although both strains were equally insulin resistant, the MUP-uPA mice exhibited more liver damage, more immune infiltration, and increased lipogenesis and, as a result, displayed classical NASH signs and developed typical steatohepatitic HCC. Both NASH and HCC development were dependent on TNF produced by inflammatory macrophages that accumulate in the MUP-uPA liver in response to hepatocyte ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several transgenic animals have been developed to study MASH pathogenesis, including those that overexpress urokinase-type plasminogen activator (MUP-uPA) (221) or sterol regulatory element-binding protein 1 (SREBP1) (222, 223).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Self-citationProtein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Cited by
Sorted by citations
Items 101–200 of 526
Mitochondrial Dysfunction in the Transition from NASH to HCC
Léveillé, M., & Estall, J. L. (2019) · Metabolites · doi:10.3390/metabo9100233 · Cited by 94
Integrative genomic analysis of mouse and human hepatocellular carcinoma
Dow, M. T., Pyke, R. M., Tsui, B., Alexandrov, L. B., Nakagawa, H., Taniguchi, K., Seki, E., Harismendy, O., Shalapour, S., Karin, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811029115 · Cited by 96
Self-citationShiau, J., Chuang, Y.-T., Tang, J., Yang, K., Chang, F., Hou, M., Yen, C., & Chang, H. (2022) · Antioxidants · doi:10.3390/antiox11091845 · Cited by 97
Li, N., Zhou, Z., Shen, Y., Xu, J., Miao, H., Xiong, Y., Xu, F., Li, B., Luo, J., & Song, B. (2016) · Hepatology · doi:10.1002/hep.29018 · Cited by 91
Nakagawa, H., Suzuki, N., Hirata, Y., Hikiba, Y., Hayakawa, Y., Kinoshita, H., Ihara, S., Uchino, K., Nishikawa, Y., Ijichi, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619416114 · Cited by 91
Self-citationAPOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression
Wang, D., Li, X., Li, J., Lu, Y., Zhao, S., Tang, X., Chen, X., Li, J., Zheng, Y., Li, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317601 · Cited by 89
Lipometabolism and Glycometabolism in Liver Diseases
Ding, H., Wang, J., Ren, H., & Shi, X. (2018) · BioMed Research International · doi:10.1155/2018/1287127 · Cited by 89
Brahma, M. K., Gilglioni, E. H., Zhou, L., Trépo, E., Chen, P., & Gurzov, E. N. (2021) · Oncogene · doi:10.1038/s41388-021-01950-y · Cited by 85
Tan, Y., Jin, Y., Wang, Q., Huang, J. L., Wu, X., & Ren, Z. (2019) · Cells · doi:10.3390/cells8101241 · Cited by 85
New drugs for NAFLD: lessons from basic models to the clinic
Reimer, K. C., Wree, A., Roderburg, C., & Tacke, F. (2019) · Hepatology International · doi:10.1007/s12072-019-10001-4 · Cited by 84
Fernandes‐da‐Silva, A., Miranda, C. S., Santana-Oliveira, D. A., Oliveira-Cordeiro, B., Rangel-Azevedo, C., Silva-Veiga, F. M., Martins, F. F., & Souza‐Mello, V. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02542-y · Cited by 86
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 103
Maillo, C., Martín, J., Sebastián, D., Hernández-Alvarez, M., García-Rocha, M., Reina, O., Zorzano, A., Fernandez, M., & Méndez, R. (2017) · Nature Cell Biology · doi:10.1038/ncb3461 · Cited by 82
Czauderna, C., Castven, D., Mahn, F. L., & Marquardt, J. U. (2019) · Cancers · doi:10.3390/cancers11081053 · Cited by 83
Donné, R., Saroul-Aïnama, M., Cordier, P., Hammoutène, A., Kaboré, C., Stadler, M., Nemazanyy, I., Galy–Fauroux, I., Herrag, M., Riedl, T., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.06.003 · Cited by 85
Shen, Z., Chen, Y., Chen, J.-R., Jou, Y., Wu, P.-C., Kao, C., Wang, C., Huang, Y., Chen, C., Huang, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.099 · Cited by 78
Sun, J., Esplugues, E., Bort, A., Cardelo, M. P., Ruz‐Maldonado, I., Fernández‐Tussy, P., Wong, C., Wang, H., Ojima, I., Kaczocha, M., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01019-6 · Cited by 79
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
Garg, A. D., Maes, H., van Vliet, A. R., & Agostinis, P. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975089 · Cited by 72
Poothong, J., Pottekat, A., Siirin, M., Campos, A. R., Paton, A. W., Paton, J. C., Lagunas-Acosta, J., Chen, Z., Swift, M. F., Volkmann, N., et al. (2020) · Blood · doi:10.1182/blood.2019002867 · Cited by 70
Self-citationCellular mechanisms linking cancers to obesity
Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 74
Wei, C.-W., Yang, X., Liu, N., Geng, J., Tai, Y., Sun, Z., Mei, G., Zhou, P., Peng, Y., Wang, C.-B., et al. (2019) · Hepatology · doi:10.1002/hep.30549 · Cited by 64
LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma
Yang, N., Yong, F., HaiBin, Z., Hui, S., Nan, Z., & Guangshun, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4661 · Cited by 71
Wu, Y., Shan, B., Dai, J., Xia, Z., Cai, J., Chen, T., Lv, S., Feng, Y., Zheng, L., Wang, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29871 · Cited by 75
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression
Latif, M. U., Schmídt, G., Mercan, S., Rahman, R., Gibhardt, C. S., Stejerean‐Todoran, I., Reutlinger, K., Heßmann, E., Singh, S. K., Moeed, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325013 · Cited by 71
Bazhabayi, M., Qiu, X., Li, X., Yang, A., Wen, W., Zhang, X., Xiao, X., He, R., & Liu, P. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16963 · Cited by 70
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 81
Getting the better of ER stress
Mollereau, B., Manié, S. N., & Napoletano, F. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-014-0251-9 · Cited by 72
Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers
Gingold, J. A., Zhu, D., Lee, D., Kaseb, A. O., & Chen, J. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.006 · Cited by 72
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 70
Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma
Wei, J., & Fang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041799 · Cited by 68
The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer
Todoric, J., & Karin, M. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.001 · Cited by 69
Self-citationWu, M., Fu, T., Chen, J.-X., Lin, Y., Yang, J.-E., & Zhuang, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2469-1 · Cited by 66
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment
González‐Romero, F., Mestre, D., Aurrekoetxea, I., O’Rourke, C. J., Andersen, J. B., Woodhoo, A., Tamayo-Caro, M., Varela‐Rey, M., Palomo-Irigoyen, M., Gómez‐Santos, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2052 · Cited by 72
Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses
Zhang, Y., Yu, X., Bao, R., Huang, H., Gu, C., Lv, Q.-M., Han, Q., Du, X., Zhao, X.-Y., Ye, Y., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.011 · Cited by 66
Qin, X., Su, T., Yu, W., & Kojima, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2257-y · Cited by 64
Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.
Karin, M., & Dhar, D. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw060 · Cited by 65
Self-citationRemodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Longo, M., Paolini, E., Meroni, M., & Dongiovanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084173 · Cited by 61
Greatorex, S., Kaur, S., Xirouchaki, C. E., Goh, P. K., Wiede, F., Genders, A. J., Tran, M., Jia, Y., Raajendiran, A., Brown, W. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162533 · Cited by 61
Chen, Y., Wang, W., Morgan, M. P., Robson, T., & Annett, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148934 · Cited by 63
Endoplasmic reticulum stress in diseases
Liu, Y., Xu, C., Gu, R., Han, R., Li, Z., & Xu, X. (2024) · MedComm · doi:10.1002/mco2.701 · Cited by 67
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Gu, L., Zhu, Y., Nandi, S. P., Lee, M., Watari, K., Bareng, B., Ohira, M., Liu, Y., Sakane, S., Carlessi, R., et al. (2025) · Nature · doi:10.1038/s41586-024-08317-9 · Cited by 63
Self-citationKishida, N., Matsuda, S., Itano, O., Shinoda, M., Kitago, M., Yagi, H., Abe, Y., Hibi, T., Masugi, Y., Aiura, K., et al. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0477-5 · Cited by 54
Luo, X.-L., Liao, R., Hanley, K. L., Zhu, H., Malo, K. N., Hernandez, C., Wei, X., Varki, N., Alderson, N. B., Chu, C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.048 · Cited by 42
Galangin potentiates human breast cancer to apoptosis induced by TRAIL through activating AMPK
Song, W., Yan, C.-Y., Zhou, Q., & Zhen, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.062 · Cited by 60
Regulatory functions of B cells and regulatory plasma cells
Fillatreau, S. (2019) · Biomedical Journal · doi:10.1016/j.bj.2019.05.008 · Cited by 60
Nakagawa, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2110 · Cited by 56
Self-citationTan, Y., Jin, Y., Wu, X., & Ren, Z. (2019) · BMC Molecular Biology · doi:10.1186/s12867-019-0141-z · Cited by 56
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
Feng, F., & Zhao, Y. (2024) · Medical Principles and Practice · doi:10.1159/000539349 · Cited by 62
ER proteostasis addiction in cancer biology: Novel concepts
Dufey, E., Urra, H., & Hetz, C. A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.003 · Cited by 58
Regulation of tumor–stroma interactions by the unfolded protein response
Obacz, J., Avril, T., Rubio‐Patiño, C., Bossowski, J. P., Igbaria, A., Ricci, J., & Chevet, É. (2017) · FEBS Journal · doi:10.1111/febs.14359 · Cited by 56
Zhou, Y., Liu, Z., Qiao, G., Tang, B., & Li, P. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.04.035 · Cited by 55
Shao, G., Liu, Y., Lu, L., Wang, L., Ji, G., & Xu, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117999 · Cited by 59
Chen, H., Zhou, B., Yang, J., Ma, X., Deng, S., Huang, Y., Wen, Y., Yuan, J.-Q., & Yang, X.-Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00483 · Cited by 48
Suzuki, K., Sentani, K., Tanaka, H., Yano, T., Suzuki, K., Oshima, M., Yasui, W., Tamura, A., & Tsukita, S. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.03.003 · Cited by 54
Romualdo, G. R., Leroy, K., Costa, C. J. S., Bacil, G. P., Vanderborght, B., da Silva, T. C., Barbisan, L. F., Andraus, W., Devisscher, L., Câmara, N. O. S., et al. (2021) · Cancers · doi:10.3390/cancers13215583 · Cited by 54
Gu, L., Zhu, Y., Lee, M., Nguyen, A., Ryujin, N. T., Huang, J. Y., Pandit, S. K., Chamseddine, S., Xiao, L., Mohamed, Y. I., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300706120 · Cited by 54
Self-citationWu, Q., Chen, J., Chen, Y., Cai, L., Wang, X.-Z., Guo, W.-H., & Zheng, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0267-9 · Cited by 53
Han, J., Song, B., Kim, J., Kodali, V. K., Pottekat, A., Wang, M., Hassler, J. R., Wang, S., Pennathur, S., Back, S. H., et al. (2015) · Diabetes · doi:10.2337/db14-1357 · Cited by 52
Self-citationHepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
Charrez, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2494 · Cited by 50
Road to stemness in hepatocellular carcinoma
Flores-Téllez, T. D. N. J., Villa‐Treviño, S., & Piña‐Vázquez, C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6750 · Cited by 52
Rutkowski, D. T. (2018) · FEBS Journal · doi:10.1111/febs.14389 · Cited by 51
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers
Shalapour, S., & Karin, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082019-081656 · Cited by 52
Self-citationTranscriptional Regulation in Non-Alcoholic Fatty Liver Disease
Steensels, S., Qiao, J., & Ersoy, B. A. (2020) · Metabolites · doi:10.3390/metabo10070283 · Cited by 53
Nakatsuka, T., Tateishi, K., Kudo, Y., Yamamoto, K., Nakagawa, H., Fujiwara, H., Takahashi, R., Miyabayashi, K., Asaoka, Y., Tanaka, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.222 · Cited by 49
Self-citationMarquardt, J. U., & Edlich, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01421 · Cited by 51
Radiation-induced liver disease: beyond DNA damage
Zhou, Y. J., Tang, Y., Liu, S. J., Zeng, P. H., Qu, L., Jing, Q., & Yin, W. J. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2131163 · Cited by 50
Ma, C., Zhang, Q., & Greten, T. F. (2017) · FEBS Journal · doi:10.1111/febs.14209 · Cited by 49
The “Janus” Role of C/EBPs Family Members in Cancer Progression
Tolomeo, M., & Grimaudo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124308 · Cited by 50
Carlessi, R., Denisenko, E., Boslem, E., Köhn‐Gaone, J., Main, N., Bakar, N. D. B. A., Shirolkar, G. D., Jones, M., Beasley, A. B., Poppe, D., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100301 · Cited by 49
Self-citationThe evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
Zanetti, M., Rodvold, J. J., & Mahadevan, N. R. (2015) · Oncogene · doi:10.1038/onc.2015.108 · Cited by 49
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041166 · Cited by 52
Vandewynckel, Y., Laukens, D., Devisscher, L., Paridaens, A., Bogaerts, E., Verhelst, X., den Bussche, A. V., Raevens, S., Steenkiste, C. V., Troys, M. V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4377 · Cited by 50
Ande, S. R., Nguyen, K. H., Nyomba, B. L. G., & Mishra, S. (2016) · Scientific Reports · doi:10.1038/srep23608 · Cited by 52
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Raza, S., Rajak, S., Anjum, B., & Sinha, R. A. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.014 · Cited by 47
Todoric, J., Umemura, A., Taniguchi, K., & Karin, M. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm027 · Cited by 46
Self-citationXiang, H., Shao, M., Lu, Y., Wang, J., Wu, T., & Ji, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690736 · Cited by 46
Noncoding RNAs in liver cancer stem cells: The big impact of little things
Lv, H., Lv, G., Han, Q., Yang, W. K., & Wang, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.001 · Cited by 44
Rimini, M., Kudo, M., Tada, T., Shigeo, S., Kang, W., Suda, G., Jefremow, A., Burgio, V., Iavarone, M. A., Tortora, R., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100330 · Cited by 44
Inflammation in MASLD progression and cancer
Kim, Y. S., Park, Y., Rho, H., Yao, T., Gao, B., & Hwang, S. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101414 · Cited by 58
van Vliet, A. R., Martin, S., Garg, A. D., & Agostinis, P. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.010 · Cited by 44
Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma
Shen, J., Tsoi, H., Liang, Q., Chu, E., Liu, D.-B., Yu, C., Chan, T., Li, X., Sung, J. J. Y., Wong, V., et al. (2016) · Oncogene · doi:10.1038/onc.2016.162 · Cited by 39
Obesity linking to hepatocellular carcinoma: A global view
Gan, L., Liu, Z., & Sun, C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.006 · Cited by 46
Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation
Sladky, V. C., & Villunger, A. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0556-6 · Cited by 39
Qi, D., Lu, M., Xu, P., Yao, X., Chen, Y., Gan, L., Li, Y., Cui, Y., Tong, X., Liu, S., et al. (2023) · 癌症:英文版 · doi:10.1002/cac2.12482 · Cited by 41
Jeelani, I., Moon, J.-S., da Cunha, F. F., Nasamran, C. A., Jeon, S., Zhang, X., Bandyopadhyay, G. K., Dobaczewska, K., Mikulski, Z., Hosseini, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0284 · Cited by 50
Sánchez‐Álvarez, M., del Pozo, M. Á., & Bakal, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16662-1 · Cited by 47
microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4
Li, Z., Zhou, Y., Zhang, L., Jia, K., Wang, S., Wang, M., Li, N., Yu, Y., Cao, X., & Hou, J. (2020) · Oncogenesis · doi:10.1038/s41389-020-00282-y · Cited by 45
Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression
Koo, J. H., & Han, C. Y. (2021) · Biomolecules · doi:10.3390/biom11020242 · Cited by 43
The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis
Goodla, L., & Xue, X. (2022) · Cells · doi:10.3390/cells11152313 · Cited by 44
Shi, C., de Wit, S., Učambarlić, E., Markousis‐Mavrogenis, G., Screever, E. M., Meijers, W. C., de Boer, R. A., & Aboumsallem, J. P. (2023) · Cancers · doi:10.3390/cancers15030729 · Cited by 51
Ando, S., Shibahara, J., Hayashi, A., & Fukayama, M. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1836-2 · Cited by 42
Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis
Chen, Y., & Tian, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01500 · Cited by 47
Wu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8641 · Cited by 41
Targeting endoplasmic reticulum stress in liver disease
Wu, F.-L., Liu, W., Poucke, S. V., Braddock, M., Jin, W., Xiao, J., Li, X., & Zheng, M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1179575 · Cited by 42
Fang, P., Xiang, L., Huang, S., Jin, L., Zhou, G., Zhuge, L., Li, J., Fan, H., Zhou, L., Pan, C., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9176 · Cited by 42
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Sun, H.-Z., Song, Y., & Wang, X. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22000 · Cited by 40
Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity
Jiang, Z., Zhang, G., Huang, L., Yuan, Y., Wu, C., & Li, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00846 · Cited by 39
Gaikwad, S. M., Phyo, Z. H., Quintanilla-Artega, A., Gorjifard, S., Calabrese, D. R., Connors, D. E., Huang, J. L., Michalowski, A. M., Zhang, S., Liu, Z.-G., et al. (2020) · Cancers · doi:10.3390/cancers12102952 · Cited by 40
Metadata
- Authors
- Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., Koike, K., Kaufman, R. J., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Kyushu University (JP)
- Universitat Autònoma de Barcelona (ES)
- The University of Tokyo (JP)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Karin, Michael
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 26
- Issue
- 3
- Pages
- 331-343
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4165611
- OpenAlex
- W2085390667
- Cited by
- 525
- References
- 38
- Citations by year
- 2026: 22 · 2025: 38 · 2024: 43 · 2023: 58 · 2022: 57 · 2021: 57 · 2020: 56 · 2019: 40 · 2018: 42 · 2017: 34 · 2016: 39 · 2015: 28 · 2014: 11
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Society for the Promotion of Science (24390183)
- National Heart, Lung, and Blood Institute (R01HL052173, HL052173-16)
- National Cancer Institute (R01CA118165, CA155120-02, R01CA155120, P30CA023100, CA118165-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088227, DK042394-18, DK088227-06)
- National Institute of Environmental Health Sciences (P42ES010337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- endoplasmic reticulum stress, overnutrition, hepatocellular carcinoma, nonalcoholic steatohepatitis, TNF-α, plasminogen activator, high-fat diet, insulin resistance, hepatic steatosis, inflammatory macrophages, lipogenesis
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Animals, Cells, Cultured, Fatty Liver, Heat-Shock Proteins, Carcinoma, Hepatocellular, Liver Neoplasms, Experimental, Male, Mice, Transgenic, Tumor Necrosis Factor-alpha, Urokinase-Type Plasminogen Activator, Signal Transduction, Overnutrition, Tumor Burden, Receptors, Tumor Necrosis Factor, Type I, Lipogenesis, Mice, Diet, High-Fat, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review